Events Partner Content Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conf... Highly Potent Active Pharmaceutical Ingredients
News AZ gets first okay for new hypertension drug baxdrostat AstraZeneca is the first company to get FDA approval for an aldosterone synthase inhibitor for hypertension, ahead of rival Mineralys.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
